ATE413878T1 - Methode zum bekämpfen der allergien durch verwendung von substituierten pyrazolen - Google Patents
Methode zum bekämpfen der allergien durch verwendung von substituierten pyrazolenInfo
- Publication number
- ATE413878T1 ATE413878T1 AT01968461T AT01968461T ATE413878T1 AT E413878 T1 ATE413878 T1 AT E413878T1 AT 01968461 T AT01968461 T AT 01968461T AT 01968461 T AT01968461 T AT 01968461T AT E413878 T1 ATE413878 T1 AT E413878T1
- Authority
- AT
- Austria
- Prior art keywords
- allergies
- fighting
- substituted pyrazoles
- pyrazoles
- substituted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23040700P | 2000-09-06 | 2000-09-06 | |
| US09/927,324 US6953793B2 (en) | 2000-08-14 | 2001-08-10 | Substituted pyrazoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE413878T1 true ATE413878T1 (de) | 2008-11-15 |
Family
ID=26924203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01968461T ATE413878T1 (de) | 2000-09-06 | 2001-09-05 | Methode zum bekämpfen der allergien durch verwendung von substituierten pyrazolen |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1315490B1 (de) |
| JP (1) | JP2004531456A (de) |
| KR (1) | KR100818056B1 (de) |
| CN (1) | CN1212839C (de) |
| AT (1) | ATE413878T1 (de) |
| AU (2) | AU8870601A (de) |
| BR (1) | BR0114054A (de) |
| CA (1) | CA2421493A1 (de) |
| CZ (1) | CZ2003635A3 (de) |
| DE (1) | DE60136546D1 (de) |
| HU (1) | HUP0302475A2 (de) |
| MX (1) | MXPA03001963A (de) |
| NZ (1) | NZ524681A (de) |
| PL (1) | PL365606A1 (de) |
| WO (1) | WO2002020011A2 (de) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1385515T1 (sl) | 2001-04-18 | 2008-12-31 | Euro Celtique Sa | Spiropirazolne spojine |
| DK1385518T3 (da) | 2001-04-18 | 2008-10-27 | Euro Celtique Sa | Benzimidazolon-forbindelser |
| PT1379246E (pt) * | 2001-04-18 | 2009-01-14 | Euro Celtique Sa | Análogos de nociceptina |
| PT1385514E (pt) | 2001-04-18 | 2009-02-04 | Euro Celtique Sa | Compostos espiroindeno e espiroindano |
| RU2268883C2 (ru) | 2001-04-18 | 2006-01-27 | Эро-Селтик, С.А. | Аналоги ноницептина и фармацевтическая композиция на их основе |
| US20030166037A1 (en) * | 2002-01-16 | 2003-09-04 | Fourie Anne M. | Aggrecanase-1 and -2 peptide substrates and methods |
| JP5069907B2 (ja) * | 2003-09-17 | 2012-11-07 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 縮合複素環式化合物 |
| US20080200454A1 (en) * | 2007-02-15 | 2008-08-21 | Ameriks Michael K | Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| EP2308866A1 (de) * | 2009-10-09 | 2011-04-13 | Bayer CropScience AG | Phenylpyri(mi)dinylpyrazole und ihre Verwendung als Fungizide |
| KR20110069692A (ko) * | 2009-12-17 | 2011-06-23 | 엘지전자 주식회사 | 광대역 이동 통신 시스템에서 긴급 서비스 정보 제공 장치 및 방법 |
| WO2012088266A2 (en) | 2010-12-22 | 2012-06-28 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3 |
| HRP20170430T1 (hr) | 2012-06-13 | 2017-06-16 | Incyte Holdings Corporation | Supstituirani triciklični spojevi kao inhibitori fgfr |
| WO2014026125A1 (en) | 2012-08-10 | 2014-02-13 | Incyte Corporation | Pyrazine derivatives as fgfr inhibitors |
| WO2014078257A1 (en) | 2012-11-14 | 2014-05-22 | Glaxosmithkline Llc | Thieno[3,2-c]pyridin-4(5h)-ones as bet inhibitors |
| US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
| PL2986610T4 (pl) | 2013-04-19 | 2019-06-28 | Incyte Holdings Corporation | Bicykliczne heterocykle jako inhibitory FGFR |
| JP6826527B2 (ja) * | 2014-09-18 | 2021-02-03 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | カテプシンｓ阻害をモニタリングするための方法 |
| US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
| WO2016134294A1 (en) | 2015-02-20 | 2016-08-25 | Incyte Corporation | Bicyclic heterocycles as fgfr4 inhibitors |
| MY197720A (en) | 2015-02-20 | 2023-07-10 | Incyte Corp | Bicyclic heterocycles as fgfr inhibitors |
| MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
| EP3319968A1 (de) | 2015-07-06 | 2018-05-16 | Rodin Therapeutics, Inc. | Heterobicyclische n-aminophenyl-amide als inhibitoren der histondeacetylase |
| SMT202100702T1 (it) | 2015-07-06 | 2022-01-10 | Alkermes Inc | Inibitori etero-alo dell'istone deacetilasi |
| US9951069B1 (en) | 2017-01-11 | 2018-04-24 | Rodin Therapeutics, Inc. | Bicyclic inhibitors of histone deacetylase |
| AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
| DK3664802T3 (en) | 2017-08-07 | 2022-05-30 | Alkermes Inc | Bicyclic inhibitors of histone deacetylase |
| JP7568512B2 (ja) | 2018-05-04 | 2024-10-16 | インサイト・コーポレイション | Ｆｇｆｒ阻害剤の塩 |
| BR112020022392A2 (pt) | 2018-05-04 | 2021-02-02 | Incyte Corporation | formas sólidas de um inibidor de fgfr e processos para preparação das mesmas |
| US11628162B2 (en) | 2019-03-08 | 2023-04-18 | Incyte Corporation | Methods of treating cancer with an FGFR inhibitor |
| WO2021007269A1 (en) | 2019-07-09 | 2021-01-14 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
| US12122767B2 (en) | 2019-10-01 | 2024-10-22 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| JP7675711B2 (ja) | 2019-10-14 | 2025-05-13 | インサイト・コーポレイション | Ｆｇｆｒ阻害剤としての二環式複素環 |
| WO2021076728A1 (en) | 2019-10-16 | 2021-04-22 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
| PE20221504A1 (es) | 2019-12-04 | 2022-09-30 | Incyte Corp | Derivados de un inhibidor de fgfr |
| CA3163875A1 (en) | 2019-12-04 | 2021-06-10 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
| WO2021146424A1 (en) | 2020-01-15 | 2021-07-22 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
| WO2022221170A1 (en) | 2021-04-12 | 2022-10-20 | Incyte Corporation | Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent |
| EP4352060A1 (de) | 2021-06-09 | 2024-04-17 | Incyte Corporation | Tricyclische heterocyclen als fgfr-inhibitoren |
| AR126102A1 (es) | 2021-06-09 | 2023-09-13 | Incyte Corp | Heterociclos tricíclicos como inhibidores de fgfr |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0615542B2 (ja) * | 1986-07-22 | 1994-03-02 | 吉富製薬株式会社 | ピラゾロピリジン化合物 |
| FR2705962B1 (fr) * | 1993-06-03 | 1995-07-13 | Rhone Poulenc Agrochimie | Arylpyrazoles fongicides. |
| US5486534A (en) * | 1994-07-21 | 1996-01-23 | G. D. Searle & Co. | 3,4-substituted pyrazoles for the treatment of inflammation |
| AU7553198A (en) * | 1997-06-12 | 1998-12-30 | Sumitomo Pharmaceuticals Company, Limited | Pyrazole derivatives |
| NZ524682A (en) * | 2000-09-06 | 2004-11-26 | Ortho Mcneil Pharm Inc | A method for treating allergies using substituted pyrazoles |
-
2001
- 2001-09-05 CZ CZ2003635A patent/CZ2003635A3/cs unknown
- 2001-09-05 WO PCT/US2001/027429 patent/WO2002020011A2/en not_active Ceased
- 2001-09-05 EP EP01968461A patent/EP1315490B1/de not_active Expired - Lifetime
- 2001-09-05 CN CNB018185010A patent/CN1212839C/zh not_active Expired - Fee Related
- 2001-09-05 NZ NZ524681A patent/NZ524681A/en unknown
- 2001-09-05 CA CA002421493A patent/CA2421493A1/en not_active Abandoned
- 2001-09-05 AT AT01968461T patent/ATE413878T1/de not_active IP Right Cessation
- 2001-09-05 PL PL01365606A patent/PL365606A1/xx not_active Application Discontinuation
- 2001-09-05 MX MXPA03001963A patent/MXPA03001963A/es active IP Right Grant
- 2001-09-05 AU AU8870601A patent/AU8870601A/xx active Pending
- 2001-09-05 DE DE60136546T patent/DE60136546D1/de not_active Expired - Fee Related
- 2001-09-05 HU HU0302475A patent/HUP0302475A2/hu unknown
- 2001-09-05 JP JP2002524495A patent/JP2004531456A/ja active Pending
- 2001-09-05 BR BR0114054-0A patent/BR0114054A/pt not_active Application Discontinuation
- 2001-09-05 AU AU2001288706A patent/AU2001288706B2/en not_active Ceased
- 2001-09-05 KR KR1020037003357A patent/KR100818056B1/ko not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1473043A (zh) | 2004-02-04 |
| MXPA03001963A (es) | 2004-03-18 |
| WO2002020011A2 (en) | 2002-03-14 |
| HK1053794A1 (en) | 2003-11-07 |
| KR100818056B1 (ko) | 2008-03-31 |
| BR0114054A (pt) | 2003-07-01 |
| EP1315490A2 (de) | 2003-06-04 |
| JP2004531456A (ja) | 2004-10-14 |
| CA2421493A1 (en) | 2002-03-14 |
| NZ524681A (en) | 2005-09-30 |
| KR20040007393A (ko) | 2004-01-24 |
| AU2001288706B2 (en) | 2006-01-19 |
| PL365606A1 (en) | 2005-01-10 |
| WO2002020011A3 (en) | 2002-06-13 |
| EP1315490B1 (de) | 2008-11-12 |
| HUP0302475A2 (hu) | 2003-11-28 |
| AU8870601A (en) | 2002-03-22 |
| CN1212839C (zh) | 2005-08-03 |
| CZ2003635A3 (cs) | 2004-12-15 |
| DE60136546D1 (de) | 2008-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE413878T1 (de) | Methode zum bekämpfen der allergien durch verwendung von substituierten pyrazolen | |
| DK1313721T3 (da) | Ikke-imidazol-aryloxyalkylaminer som H3-receptorligander | |
| DK1311482T3 (da) | Ikke-imidazolaryloxypiperidiner som H3-receptorligander | |
| NO20062099L (no) | Synergistiske fungicide aktive substanskombinasjoner | |
| NO20062337L (no) | Synergistiske fungicidiale aktive forbindelser | |
| NO20091976L (no) | Nye forbindelser | |
| NO20082266L (no) | Nye 1-azabicykloalkylderivater for behandling av psykotiske og neurodegenerative forstyrrelser | |
| DE60135130D1 (de) | Verwendung von substituierten pyrazolen zur behandlung von allergien | |
| MXPA05011962A (es) | Oxiarenos substituidos. | |
| MXPA05004384A (es) | Piperacinil y diacepanil benzamidas y benztioamidas. | |
| DE602004005881D1 (de) | Substituierte pyrazinonverbindungen zur behandlung von entzündungen | |
| DE602004016316D1 (de) | 4-(2-phenylsulfanyl-phenyl)-piperidin-derivate als serotonin-wiederaufnahme-hemmer | |
| DK1513800T3 (da) | Benzoylureido-kanelsyrederivater, fremgangsmåde til deres anvendelse | |
| DE602004018811D1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren | |
| DE60219950D1 (de) | Verfahren zur überwachung/bekämpfung von thysanoptera | |
| DE602004012965D1 (de) | Verfahren zum Bleichen | |
| CY1112457T1 (el) | Χρωμανο- και θειοxρωμανο-3-υλο-1,3-διυδρο-ιμιδαζολια ως αναστολεις της ντοπαμινο-β-υδροξυλασης, και μεθοδοι παρασκευης αυτων | |
| DE60122171D1 (de) | Verwendung von substituierten pyrazolen zur herstellung eines medikaments zur behandlung von allergien | |
| EA199801084A1 (ru) | Спосб получения фенилгетероциклических соединений, используемых в качестве ингибиторов циклооксигеназы-2 | |
| DE602006012938D1 (de) | Neue 6-pyridylphenanthridine | |
| CY1107922T1 (el) | Μεθοδος για την παρασκευη 4-πενταφθοροσουλφανυλο-βενζοϋλογουανιδινων | |
| DE602004019698D1 (de) | Morpholinderivate als inhibitoren der wiederaufnahme von norepinephrin | |
| EA200501580A1 (ru) | Производные 4-(2-фенилоксифенил)пиперидина или -1,2,3,6- тетрагидропиридина в качестве ингибиторов обратного захвата серотонина | |
| ATE437846T1 (de) | Cyclooct-(en-)yl-derivate zur verwendung als duftstoffe | |
| ATE418121T1 (de) | Verfahren zum betreiben einer chipkarte, auf der mehrere applikationen implementiert sind |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |